Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.710
-0.090 (-5.00%)
At close: Mar 5, 2026, 4:00 PM EST
1.710
0.00 (0.00%)
Pre-market: Mar 6, 2026, 7:22 AM EST
Caribou Biosciences Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Caribou Biosciences stock have an average target of 10, with a low estimate of 8.00 and a high estimate of 13. The average target predicts an increase of 484.80% from the current stock price of 1.71.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 2, 2026.
Analyst Ratings
The average analyst rating for Caribou Biosciences stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Clear Street | Clear Street | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +660.23% | Feb 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $9 | Strong Buy | Maintains | $3 → $9 | +426.32% | Nov 5, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $5 → $8 | Strong Buy | Maintains | $5 → $8 | +367.84% | Nov 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $3 | Strong Buy | Maintains | $9 → $3 | +75.44% | Apr 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +426.32% | Mar 19, 2025 |
Financial Forecast
Revenue This Year
9.90M
from 9.99M
Decreased by -0.98%
Revenue Next Year
10.43M
from 9.90M
Increased by 5.37%
EPS This Year
-1.64
from -1.65
EPS Next Year
-1.37
from -1.64
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 11.0M | 12.1M | ||||
| Avg | 9.9M | 10.4M | ||||
| Low | 8.8M | 9.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.2% | 22.0% | ||||
| Avg | -1.0% | 5.4% | ||||
| Low | -11.7% | -7.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.58 | -0.86 | |
| Avg | -1.64 | -1.37 | |
| Low | -1.62 | -1.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.